DCM
FLGT icon

Driehaus Capital Management’s Fulgent Genetics FLGT Stock Holding History

Driehaus Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-104,453
Closed -$10.1M – 468
2021
Q1 		$10.1M Sell
104,453
-166,192
-61% -$17.2M 0.15% 204
2020
Q4 		$14.1M Buy
270,645
+116,791
+76% +$4.88M 0.23% 126
2020
Q3 		$6.16M Buy
+153,854
New +$4.82M 0.13% 187
2020
Q2 		– Sell
-667,996
Closed -$7.19M – 420
2020
Q1 		$7.19M Buy
667,996
+117,812
+21% +$1.64M 0.24% 110
2019
Q4 		$7.1M Buy
550,184
+487,084
+772% +$5.79M 0.19% 140
2019
Q3 		$656K Buy
+63,100
New +$598K 0.02% 382

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Driehaus Capital Management's FLGT Position: Q2 2021 in Review

Driehaus Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2021, closing a stake of 104,453 shares — an estimated $10.1M sold.

Driehaus Capital Management first reported a position in FLGT in Q3 2019 and held it in 6 quarters. The position peaked at $14.1M in Q4 2020. 254 funds tracked by Wall St. Rank hold FLGT as of Q2 2021.

  • Driehaus Capital Management reported no remaining Fulgent Genetics position as of Q2 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 104,453 Fulgent Genetics shares in Q2 2021, an estimated $10.1M.
  • Driehaus Capital Management first reported a position in Fulgent Genetics in Q3 2019 and held it in 6 quarters.
  • Driehaus Capital Management's Fulgent Genetics position peaked at $14.1M in Q4 2020.
  • 254 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2021.

Based on Driehaus Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.